APA (7th ed.) Citation

CM, B., TY, F., S, B., UK, B., M, J., I, L., . . . FS, D. C. (2026). Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression. Molecular cancer therapeutics, 25(1), 156. https://doi.org/10.1158/1535-7163.MCT-25-0437

Chicago Style (17th ed.) Citation

CM, Burke, et al. "Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression." Molecular Cancer Therapeutics 25, no. 1 (2026): 156. https://doi.org/10.1158/1535-7163.MCT-25-0437.

MLA (9th ed.) Citation

CM, Burke, et al. "Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression." Molecular Cancer Therapeutics, vol. 25, no. 1, 2026, p. 156, https://doi.org/10.1158/1535-7163.MCT-25-0437.